Cas 1004528-08-8,methyl 1-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-4-carboxylate

1004528-08-8

Post Buying Request

Basic information

Product Name: methyl 1-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-4-carboxylate
Synonyms: methyl 1-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-4-carboxylate
CAS NO:1004528-08-8
Molecular Formula:
Molecular Weight: 287.318
EINECS: N/A
Product Categories: N/A
Mol File: 1004528-08-8.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: methyl 1-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-4-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: methyl 1-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-4-carboxylate(1004528-08-8)
EPA Substance Registry System: methyl 1-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-4-carboxylate(1004528-08-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1004528-08-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1004528-08-8 Suppliers

Recommended suppliersmore

1004528-08-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1004528-08-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,5,2 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1004528-08:
(9*1)+(8*0)+(7*0)+(6*4)+(5*5)+(4*2)+(3*8)+(2*0)+(1*8)=98
98 % 10 = 8
So 1004528-08-8 is a valid CAS Registry Number.

1004528-08-8Upstream product

1004528-08-8Downstream Products

1004528-08-8Relevant articles and documents

AMIDE COMPOUNDS

-

Page/Page column 171-172, (2008/06/13)

The present invention provides compounds represented by the formula (Ie) and the formula (If) wherein each symbol is as defined in the specification. According to the present invention, these compounds have a DGAT inhibitory activity and are useful for the prophylaxis, treatment or improvement of diseases or pathologies caused by high expression or high activation of DGAT

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1004528-08-8